Actively Recruiting
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
Led by Orlando Health, Inc. · Updated on 2025-11-14
200
Participants Needed
1
Research Sites
98 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.
CONDITIONS
Official Title
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years old or greater
- Patients undergoing EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract
You will not qualify if you...
- Age less than 18 years
- Patients not undergoing sampling of solid mass lesions at EUS
- Patients with cystic lesions in the gastrointestinal tract
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Orlando Health Digestive Health Institute
Orlando, Florida, United States, 32806
Actively Recruiting
Research Team
J
Ji Young Bang, MD MPH
CONTACT
B
Barbara J Broome
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here